Pembrolizumab and Cabozantinib in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma (RMHNSCC): 2-year Long Term Survival Update with Biomarker Analysis

被引：0
|
作者：
Saba, N. F. [1 ]
Ekpenyong, A. [1 ]
McCook, A. [1 ]
Schmitt, N. C. [1 ]
Gross, J. H. [1 ]
Rudra, S. F. [1 ]
Stokes, W. A. [2 ]
Kirtane, K. [3 ]
Chaudhary, R. [4 ]
Biernacki, M. [4 ]
Slebos, R. [4 ]
Song, X. [4 ]
Steuer, C. [5 ]
Shin, D. M. [5 ]
Teng, Y. F. [1 ]
Liu, Y. [6 ]
Chung, C. H. [3 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Emory Univ, Winship Canc Inst, Dept Radiat Oncol, Atlanta, GA 30322 USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[5] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
[6] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 118卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2
引用
收藏
页码：E3 / E3
页数：1
相关论文
共 50 条
  • [21] Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: Hypothesis coming from the subgroup analysis
    De Felice, Francesca
    Bossi, Paolo
    [J]. ORAL ONCOLOGY, 2023, 137
  • [22] Immunotherapy in recurrent and or metastatic squamous cell carcinoma of the head and neck
    Saada-Bouzid, Esma
    Peyrade, Frederic
    Guigay, Joel
    [J]. CURRENT OPINION IN ONCOLOGY, 2019, 31 (03) : 146 - 151
  • [23] Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
    Hsieh, Ronan W.
    Borson, Steven
    Tsagianni, Anastasia
    Zandberg, Dan P.
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [24] Chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck
    Fanucchi, M
    Khuri, FR
    [J]. SEMINARS IN ONCOLOGY, 2004, 31 (06) : 809 - 815
  • [25] Safety evaluation of pembrolizumab for treating recurrent head and neck squamous cell carcinoma
    Desilets, Antoine
    Soulieres, Denis
    [J]. EXPERT OPINION ON DRUG SAFETY, 2020, 19 (08) : 927 - 933
  • [26] Efficacy and safety of pembrolizumab in Chinese patients with recurrent/unresectable/metastatic head and neck squamous cell carcinoma.
    Li, Jieying
    Song, Kai
    Feng, Yuanyong
    Shang, Wei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18001 - E18001
  • [27] Serum Albumin as an Independent Predictor of Long-Term Survival in Patients with Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma Treated with Nivolumab
    Suzuki, Shinsuke
    Taguchi, Yukie
    Kitabayashi, Takuro
    Sato, Nobuko
    Kaya, Haruka
    Abe, Tomoe
    Endo, Tentaro
    Suzuki, Hitomi
    Kawasaki, Yohei
    Yamada, Takechiyo
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (09)
  • [28] Biomarkers and response to pembrolizumab (pembro) in recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).
    Chow, Laura Quan Man
    Mehra, Ranee
    Haddad, Robert I.
    Mahipal, Amit
    Weiss, Jared
    Berger, Raanan
    Eder, Joseph Paul
    Burtness, Barbara
    Tahara, Makoto
    Keam, Bhumsuk
    Le, Dung T.
    Muro, Kei
    Geva, Ravit
    Chung, Hyun Cheol
    Lin, Chia-Chi
    Ayers, Mark
    Aurora-Garg, Deepti
    Lunceford, Jared K.
    Cheng, Jonathan D.
    Seiwert, Tanguy Y.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [29] Transoral Robotic-Assisted Surgery for Head and Neck Squamous Cell Carcinoma One- and 2-Year Survival Analysis
    White, Hilliary N.
    Moore, Eric J.
    Rosenthal, Eben L.
    Carroll, William R.
    Olsen, Kerry D.
    Desmond, Renee A.
    Magnuson, J. Scott
    [J]. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2010, 136 (12) : 1248 - 1252
  • [30] Advances in the management of recurrent or metastatic squamous cell carcinoma of the head and neck
    Shin, Dong M.
    Khuri, Fadlo R.
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2013, 35 (03): : 443 - 453
12345